MASI Learn · Vitamin K map, bone–vascular biology and catalog-honest program fit
Why do people ask whether David Sinclair takes vitamin K — and what does the evidence actually say? Public longevity conversations often fold vitamin K into “anti-aging stacks” because vitamin K-dependent proteins help keep calcium in the right places: activated in bone matrix proteins and restrained in soft-tissue calcification pathways.12789 That biology is real. Celebrity regimen chatter is not a personal prescription, and MASI does not sell vitamin K1, vitamin K2 (MK-4/MK-7), calcium megadoses, warfarin alternatives or bone drugs.
This guide answers the vitamin K question first, separates K1 from K2/menaquinones, calibrates human observational and trial evidence without hype, flags anticoagulant interactions, and then places a catalog-honest MASI cellular program beside nutrition basics — Premium NMN → meal-timed Premium Resveratrol, with optional Spermidine, Premium Fisetin and Hair Complex by goal.171819202122
Educational longevity content — not medical advice, not a clinician–patient relationship, and not affiliation with Dr. Sinclair or his institutions.
Direct answer
- Public signal: Vitamin K shows up in longevity media because activated vitamin K-dependent proteins (including osteocalcin and matrix Gla protein pathways) sit at the intersection of bone quality and soft-tissue calcification biology — not because a podcast creates a universal dosing protocol.89115
- Forms matter: K1 (phylloquinone) is the leafy-green dominant form tightly linked to clotting-factor carboxylation. K2 menaquinones (MK-4, MK-7 and related forms) dominate many heart/bone intake studies and fermented-food discussions.6112
- Human evidence flavor: Stronger for dietary patterns and selected markers (coronary calcification/CHD associations with higher menaquinone intake; MK-7 arterial-stiffness trial signals; bone/osteocalcin carboxylation literature) than for “anti-aging miracle” disease claims. Critical cardiovascular reviews still urge evidence before enthusiasm.123457
- Safety first: Anticoagulation interactions are not optional reading. Food-first vitamin K is different from unsupervised high-dose stacking if you take warfarin-class medicines.
- MASI’s honest role: We do not sell vitamin K. We sell named cellular longevity supplements you can run after nutrition and training basics, with clear product paths and no invented bone-drug claims.
Program snapshot: Eat leafy greens and fermented/vitamin-K-aware foods if your clinician agrees. Lift 2–4×/week and keep protein adequate for muscle and bone loading. Leave anticoagulation and osteoporosis drugs to medical care. Then use Premium NMN daily and Premium Resveratrol with a fat-containing meal as the MASI cellular foundation; add Spermidine or Premium Fisetin by goal, and Hair Complex when hair is primary. Reassess energy, training, waist and clinician labs by day 90.
Affiliation and catalog boundary: MASI Longevity Science is independent and not endorsed by Dr. Sinclair or his institutions. This page explains vitamin K biology and how customers who land on “Sinclair vitamin K” queries can still build a coherent longevity program. It is educational product guidance — not a biography of anyone’s medicine cabinet.
Why vitamin K enters anti-aging conversations
Customers usually mean one of three things: copy a public stack, protect bones while taking calcium/D, or worry about arteries calcifying with age. A clinically useful answer does not pretend those are the same shopping cart.
Vitamin K is a family of fat-soluble cofactors required to carboxylate specific Gla proteins. When those proteins are under-carboxylated, bone matrix quality and calcification control can both look worse in research settings — which is why bone and vascular literatures keep crossing.891110
K1 vs K2: practical taxonomy
Vitamin K1 (phylloquinone)
Dominant in green vegetables. Central to hepatic clotting-factor activation. Diet quality often moves K1 more than exotic capsules.616
Vitamin K2 (menaquinones)
Includes MK-4 and longer-chain forms such as MK-7 (often discussed with natto and some fermented foods). Extra-hepatic distribution is a major reason vascular and bone papers emphasize menaquinones.6124
What “activation” means
Carboxylated osteocalcin and matrix Gla protein pathways are the mechanistic bridge people cite when they say vitamin K “puts calcium in bone, not arteries.” Mechanism is not automatic disease prevention for every adult.8911
What MASI will not claim
We will not sell “Sinclair K2” kits, invent a MASI vitamin K SKU, or imply NMN replaces vitamin K nutrition or osteoporosis therapy.
What human evidence supports — and what it does not
| Domain | Signal people cite | Evidence flavor | Practical reading |
|---|---|---|---|
| Coronary calcification / CHD | Higher dietary menaquinone intake associated with less coronary calcification and lower CHD rates in Dutch cohort work | Observational intake epidemiology (Rotterdam and follow-ons)123 | Supports food-pattern interest — not proof a capsule reverses plaque |
| Arterial stiffness | MK-7 improved arterial stiffness measures in healthy postmenopausal women in an RCT | Double-blind randomized trial4 | Useful vascular-marker signal; still not a standalone cardiology plan |
| Bone / fractures | Vitamin K literature includes osteocalcin carboxylation, bone-health reviews and fracture meta-analysis work; natto/MK-7 meta-analyses continue in Asian cohorts | Mixed RCT/meta + mechanistic bone papers781213 | Resistance training + protein + clinician bone care still dominate |
| Mortality / critical reviews | Intake–mortality associations exist; cardiovascular benefit reviews urge caution against over-claiming | Observational + critical synthesis14515 | Stay humble; prefer food patterns and medical context |
| Soft-tissue calcification biology | Vitamin K status and MGP carboxylation sit in calcification-control models | Mechanistic and biomarker literature91011 | Explains the “why K” story without disease-cure language |
A careful reading of the cardiovascular vitamin K literature is exactly what serious customers want: interesting nutrient biology, selected human signals, and explicit limits — not a sales argument dressed as a miracle pathway.5
Food-first before capsules
- Leafy greens and mixed plants: practical K1 density for most omnivore and many vegetarian patterns.
- Fermented foods where culturally appropriate: natto is the classic high-MK-7 example in research diets; not everyone will or should eat it daily.126
- Fat-containing meals: vitamin K is fat-soluble; absorption context matters more than empty-stomach folklore wars.
- Do not megadose calcium and ignore vitamin K/D/protein/loading: bone is a system, not a single pill.824
Safety: anticoagulation and medical red flags
If you take warfarin or another vitamin K-sensitive anticoagulant, changing vitamin K intake can move INR and bleeding/clotting risk. That is a clinician and monitoring problem — not a blog titration. People with known clotting disorders, recent thrombosis, planned surgery, advanced kidney disease or active osteoporosis drug plans need individualized medical guidance before supplement experiments.
Educational boundary: nothing here diagnoses, treats or replaces prescribed therapy for cardiovascular disease, fracture risk or coagulation disorders.24
Where MASI products fit when the query is vitamin K
Customers who land here still want a coherent longevity program. Vitamin K nutrition is not a MASI SKU. Cellular energy and maintenance molecules are.
Premium NMN
Supports NAD+ precursor pathways tied to cellular energy metabolism. Human pilot data include muscle insulin-sensitivity signals in selected adults — a cellular layer, not a bone drug or vitamin K substitute.17181923
Premium Resveratrol
Polyphenol used with a fat-containing meal in MASI programs. Short human energy-metabolism work sits beside long mechanism literature.20
Spermidine & Premium Fisetin
Optional cellular-maintenance and senescence-research context after foundation — still not vitamin K, calcium or bisphosphonate replacements.2122
Hair Complex
Use when hair is a primary outcome. Keep it goal-specific rather than forcing every SKU into a bone narrative.
| Decision | What “good” usually looks like | Evidence flavor | Practical reading |
|---|---|---|---|
| Vitamin K nutrition | Food-first K1/K2 patterns; clinician-guided supplements only if indicated | Intake epidemiology; MK-7 RCT stiffness; bone reviews148 | Outside MASI catalog — still teach it honestly |
| Bone loading | Resistance training, protein adequacy, fall-risk basics | Healthy-aging frameworks2425 | Higher leverage than celebrity capsule lists |
| Cellular foundation | Daily Premium NMN + meal-timed Premium Resveratrol | NAD+/NMN and resveratrol human/mechanism map17181920 | MASI’s commercial lane |
| Optional breadth | Spermidine / fisetin / Hair Complex by goal | Autophagy and senescence literature2122 | Add after foundation |
| Medical therapy | Anticoagulation, osteoporosis drugs, cardiology plans | Indication-specific care | Never replaced by this page |
For a broader bone-nutrient orientation on MASI’s content spine, see the live bone-health map. For prescription vs consumer stack boundaries in Sinclair-era media, see the regimen map.
90-day implementation plan
- Days 1–14 — nutrition and loading: Add leafy greens most days if medically appropriate. Note fermented-food options you actually enjoy. Start or restart 2 resistance sessions/week. List every anticoagulant or bone medicine you take and do not change them from a blog.
- Days 15–45 — MASI foundation: Add Premium NMN daily and Premium Resveratrol with a fat-containing meal. Keep training progressive. If a clinician manages clotting or osteoporosis, keep them in the loop before any new supplement.
- Days 46–90 — personalize without fake K claims: Optionally add Spermidine or Premium Fisetin. Use Hair Complex if hair is primary. Reassess energy, strength, waist and clinician labs. Still no unsupervised warfarin-stack experiments.
What success looks like: steadier training capacity, better meal pattern quality, clear separation between nutrient education and MASI cellular products, and zero confusion that NMN “is vitamin K.” If bone density, fracture risk or clotting is the real clinical issue, your clinician’s plan outranks any longevity article — including this one.
FAQ
Why does David Sinclair take vitamin K?
Public longevity discussion often includes vitamin K because vitamin K-dependent proteins support bone-matrix carboxylation and help regulate soft-tissue calcification biology. Media mentions are not a personal medical plan for you and are not MASI medical advice.895
Does MASI sell vitamin K or a Sinclair-branded K product?
No. MASI is independent and not endorsed by Dr. Sinclair. We do not sell vitamin K1, MK-4, MK-7 or calcium-only bone kits. Catalog products include Premium NMN, Premium Resveratrol, Spermidine, Premium Fisetin and Hair Complex.
K1 or K2 — which matters more?
Both matter for different reasons. K1 is the leafy-green workhorse tied tightly to clotting-factor carboxylation; K2 menaquinones are over-represented in many vascular and bone intake discussions and in MK-7 trials. Food pattern usually beats identity-politics between forms.641
Can vitamin K reverse artery calcification?
Do not count on reverse-plaque promises from a supplement page. Observational menaquinone intake associations and selected MK-7 stiffness data are interesting; they are not a substitute for cardiology care or proven cardiovascular drugs when those are indicated.245
What if I take warfarin or other blood thinners?
Do not start, stop or megadose vitamin K without your prescribing clinician and monitoring plan. Intake changes can move anticoagulation control. This page cannot manage that risk for you.
How should I use MASI products if bone and aging are my goals?
Keep nutrition, progressive resistance training and clinician-guided bone or vascular care first. Then run a catalog-honest cellular layer: Premium NMN daily, Premium Resveratrol with food, and optional spermidine/fisetin/Hair Complex by goal. That is complementary biology — not a vitamin K replacement claim.171820
References
- Geleijnse JM, et al. Dietary intake of menaquinone and coronary heart disease — Rotterdam Study. J Nutr. 2004. PubMed 15514282.
- Beulens JW, et al. High dietary menaquinone intake and coronary calcification. Atherosclerosis. 2009. PubMed 18722618.
- Gast GC, et al. High menaquinone intake and coronary heart disease incidence. Nutr Metab Cardiovasc Dis. 2009. PubMed 19179058.
- Knapen MH, et al. Menaquinone-7 and arterial stiffness in healthy postmenopausal women (RCT). Thromb Haemost. 2015. PubMed 25694037.
- Shea MK, et al. Evidence before enthusiasm — potential cardiovascular benefits of vitamin K (critical review). Adv Nutr. 2021. PubMed 33684212.
- Schurgers LJ, et al. Synthetic vitamin K1 vs natto-derived menaquinone-7. Blood. 2007. PubMed 17158229.
- Cockayne S, et al. Vitamin K and fracture prevention — systematic review/meta-analysis. Arch Intern Med. 2006. PubMed 16801507.
- Weber P. Vitamin K and bone health. Nutrition. 2001. PubMed 11684396.
- Theuwissen E, et al. Vitamin K and soft-tissue calcification. Adv Nutr. 2012. PubMed 22516724.
- Spronk HM, et al. Menaquinone-4 and arterial calcification in warfarin-treated rats. J Vasc Res. 2003. PubMed 14654717.
- Higher circulating dp-ucMGP over time and survival — Maastricht cohort signal. PubMed 38111069.
- Habitual natto intake, serum MK-7, osteocalcin carboxylation and bone density — meta-analysis of Japanese data. PubMed 41393956.
- Vitamin K and women’s health — review. PubMed 40718363.
- Vitamin K intake and mortality associations. PubMed 27640076.
- Circulating phylloquinone, inactive MGP and CHD risk — Mendelian randomization. PubMed 31103344.
- Epigenome-wide signature of phylloquinone supplementation response. PubMed 32090699.
- Covarrubias AJ, et al. NAD+ metabolism in ageing. Nat Rev Mol Cell Biol. 2021. PubMed 33353981.
- Yoshino M, et al. NMN increases muscle insulin sensitivity in prediabetic women. Science. 2021. PubMed 33888596.
- Yoshino J, et al. NAD+ intermediates — biology of NMN and NR. Cell Metab. 2018. PubMed 29249689.
- Timmers S, et al. Resveratrol and energy metabolism in obese humans. Cell Metab. 2011. PubMed 22055504.
- Madeo F, et al. Spermidine in health and disease. Science. 2018. PubMed 29371440.
- Yousefzadeh MJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018. PubMed 30279143.
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014. PubMed 24786309.
- Partridge L, et al. From ageing discoveries to therapeutics for healthy ageing. Nat Rev Drug Discov. 2020. PubMed 31292558.
- de Cabo R, Mattson MP. Intermittent fasting and healthspan. N Engl J Med. 2019. PubMed 31881139.
Build the program you can actually run. Keep vitamin K in the nutrition and medical lane. Use MASI for a clear cellular stack with path-only product links.
Educational only. Not medical advice. Not a substitute for anticoagulation, bone or cardiovascular care. MASI products are food supplements, not medicines, and are not intended to diagnose, treat, cure or prevent disease.